Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avanos Medical Inc

AVNS
Current price
18.68 USD -0.63 USD (-3.26%)
Last closed 19.15 USD
Company avanos.com
ISIN US05350V1061
Sector Healthcare
Industry Medical Devices
Exchange NYSE
Capitalization 937 982 336 USD
Yield for 12 month -12.75 %
1Y
3Y
5Y
10Y
15Y
AVNS
21.11.2021 - 28.11.2021

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Address: 5405 Windward Parkway, Alpharetta, GA, United States, 30004

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

22.5 USD

P/E ratio

43.4255

Dividend Yield

Current Year

+673 300 000 USD

Last Year

+820 000 000 USD

Current Quarter

+170 400 000 USD

Last Quarter

+171 700 000 USD

Current Year

+382 700 000 USD

Last Year

+450 000 000 USD

Current Quarter

+92 900 000 USD

Last Quarter

+95 600 000 USD

Key Figures AVNS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 102 200 000 USD
Operating Margin TTM 9.68 %
PE Ratio 43.4255
Return On Assets TTM 2.08 %
PEG Ratio
Return On Equity TTM 1.77 %
Wall Street Target Price 22.5 USD
Revenue TTM 681 500 032 USD
Book Value 26.73 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -0.5 %
Dividend Yield
Gross Profit TTM 450 000 000 USD
Earnings per share 0.47 USD
Diluted Eps TTM 0.47 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -37.5 %
Profit Margin 2.3 %

Dividend Analytics AVNS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AVNS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AVNS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 43.4255
Forward PE
Enterprise Value Revenue 1.5425
Price Sales TTM 1.3763
Enterprise Value EBITDA 12.4107
Price Book MRQ 0.7628

Financials AVNS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AVNS

For 52 weeks

17.39 USD 25.36 USD
50 Day MA 22.75 USD
Shares Short Prior Month 819 463
200 Day MA 20.87 USD
Short Ratio 3.19
Shares Short 754 811
Short Percent 2.34 %